Enhanced Tuberculosis Case Detection Among Substitution Treatment Patients

The purpose of this study was to determine the prevalence of latent tuberculosis infection among injecting drug users and to conduct randomized controlled trial to evaluate a case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program in Estonia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tuberculosis Actinomycetales Infections Bacterial Infections Bacterial Infections and Mycoses Gram-Positive Bacterial Infections Infections Mycobacterium Infections

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

LLC Corrigo

Jõhvi, Ida-Virumaa, 41532, Estonia

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Participation in substitution treatment program,
Age 18 years or more,
Able to read and write in Estonian or Russian,
Able to provide informed consent

Treatment and study plan

Case management approach in referral to health care services

Other

Case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program

Sponsors and collaborators

Lead sponsor

National Institute for Health Development, Estonia

Other Gov

Collaborators

Ida-Viru Central Hospital, Department of Tuberculosis
LLC Corrigo

Registry information

Official study title

Prevalence of Latent Tuberculosis and Enhanced Tuberculosis Case Detection Among Injecting Drug Users Receiving Methadone Substitution Treatment

Acronym: TBIDU

Important dates

Study start: 2007
Primary completion: 2008
Study completion: 2008
First posted: Feb 4, 2011
Registry last updated: Feb 4, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed